Reply to A.W. Chan et al
- PMID: 38320232
- PMCID: PMC11095854
- DOI: 10.1200/JCO.23.02566
Reply to A.W. Chan et al
Conflict of interest statement
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (
Comment on
-
Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial.J Clin Oncol. 2024 Jan 1;42(1):38-46. doi: 10.1200/JCO.23.00753. Epub 2023 Sep 25. J Clin Oncol. 2024. PMID: 37748124 Free PMC article. Clinical Trial.
References
-
- Chan AW, Simone CB, II, van der Linden Y, et al. Prophylactic radiation therapy for high-risk asymptomatic bone metastases: A new standard of care or need for more data? J Clin Oncol 42:1326–1327.2024 - PubMed
-
- Tsai CJ, Yang JT, Shaverdian N, et al. Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study Lancet 403171-1822024 - PMC - PubMed
-
- Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop. 1989;249:256–264. - PubMed
-
- Fourney DR, Frangou EM, Ryken TC, et al. Spinal Instability Neoplastic Score: An analysis of reliability and validity from the Spine Oncology Study Group. J Clin Oncol. 2011;29:3072–3077. - PubMed
Publication types
LinkOut - more resources
Full Text Sources